Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Population Health Metrics
Published in: Population Health Metrics 1/2015

Open Access 01-12-2015 | Research

Multiple biomarker models for improved risk estimation of specific cardiovascular diseases related to metabolic syndrome: a cross-sectional study

Authors: Evan Coffman, Jennifer Richmond-Bryant

Published in: Population Health Metrics | Issue 1/2015

Login to get access

Abstract

Background

Metabolic syndrome (MetS) is the co-occurrence of several conditions that increase risk of chronic disease and mortality. Multivariate models for calculating risk of MetS-related diseases based on combinations of biomarkers are promising for future risk estimation if based on large population samples. Given biomarkers’ nonspecificity and commonality in predicting diseases, we hypothesized that unique combinations of the same clinical diagnostic criteria can be used in different multivariate models to develop more accurate individual and cumulative risk estimates for specific MetS-related diseases.

Methods

We utilized adult biomarker and cardiovascular disease (CVD) data from the National Health and Nutrition Examination Survey as part of a cross-sectional analysis. Serum C-reactive protein (CRP), glycohemoglobin, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total cholesterol, fasting glucose, and apolipoprotein-B were modeled. CVDs included congestive heart failure, coronary heart disease, angina, myocardial infarction, and stroke. Decile analysis for disease prevalence in each biomarker group and multivariate logistic regression for estimation of odds ratios were employed to measure the joint association between multiple biomarkers and CVD diagnoses.

Results

Of the biomarkers considered, glycohemoglobin, triglycerides, and CRP were consistently associated with the CVD outcomes of interest in decile analysis and were selected for the final models. Associations were overestimated when using single-marker models in comparison with full models; individual odds ratios decreased an average of 16.4% from the single-biomarker models to the joint association models for CRP, 6.6% for triglycerides, and 1.4% for glycohemoglobin. However, joint associations were stronger than any single-marker estimate. Additionally, reduced models produced unique combinations of biomarkers for specific CVD outcomes.

Conclusion

The reduced joint association modeling results suggest that unique combinations of biomarkers with their related measure of association can be used to produce more accurate cumulative risk estimates for each CVD. Additionally, our results indicate that the use of multiple biomarkers in a single multivariate model may provide increased accuracy of individual biomarker association estimates by controlling for statistical artifacts and spurious relationships due to co-biomarker confounding.
Appendix
Available only for authorised users
Literature
1.
Beltran-Sanchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population. J Am Coll Cardiol 2013. 1999;62(8):697–703.CrossRef
2.
Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066–72.CrossRefPubMed
3.
Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/american heart association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24(2):e13–18.CrossRefPubMed
4.
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA. 2002;287(3):356–9.CrossRefPubMed
5.
Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159(10):1104–9.CrossRefPubMed
6.
Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836–43.CrossRefPubMed
7.
Anand IS, Florea VG, Fisher L. Surrogate end points in heart failure. J Am Coll Cardiol. 2002;39(9):1414–21.CrossRefPubMed
8.
Koenig W. Cardiovascular biomarkers: added value with an integrated approach? Circulation. 2007;116(1):3–5.CrossRefPubMed
9.
Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.CrossRefPubMed
10.
Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003.CrossRefPubMed
11.
Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation. 2002;105(3):310–5.CrossRefPubMed
12.
13.
14.
15.
16.
17.
18.
Curtin LR, Mohadjer LK, Dohrmann SM, Montaquila JM, Kruszan-Moran D, Mirel LB, et al. The National Health and Nutrition Examination Survey: Sample Design, 2007–2010. Vital and health statistics Series 2, Data evaluation and methods research. 2013(160):1–32
19.
Curtin LR, Mohadjer LK, Dohrmann SM, Montaquila JM, Kruszan-Moran D, Mirel LB, et al. The National Health and Nutrition Examination Survey: Sample Design, 1999–2006. Vital and health statistics Series 2, Data evaluation and methods research 2012(155):1–39.
20.
21.
22.
23.
24.
25.
26.
Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszan-Moran D, Dohrmann SM, et al. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat 2 Data evaluation and methods research. 2013;161:1–24.PubMed
27.
Winquist A, Kirraine E, Klein M, Strickland M, Darrow L, Sarnat S, et al. Joint effects of ambient air pollutants on pediatric asthma emergency department visits in Atlanta, 1998–2004. Epidemiology 2014.
28.
29.
Kleinbaum D, Klein M. Logistic regression - a self learning text. In. Gail M, Krickeberg K, Samet J, Tsiatis A, Wong W, editors. Third edn. New York: Springer; 2010
30.
Heeringa S, Brady WT, Berglund PA. Applied Survey Data Analysis. Boca Raton: Taylor & Francis; 2010.CrossRef
31.
Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons; 2000.CrossRef
32.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143–3421.
33.
Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363–9.CrossRefPubMed
34.
Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391–7.CrossRefPubMed
35.
Sakkinen P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP. C-reactive protein and myocardial infarction. J Clin Epidemiol. 2002;55(5):445–51.CrossRefPubMed
36.
Myint PK, Sinha S, Wareham NJ, Bingham SA, Luben RN, Welch AA, et al. Glycated hemoglobin and risk of stroke in people without known diabetes in the european prospective investigation into cancer (EPIC)-Norfolk prospective population study: a threshold relationship? Stroke. 2007;38(2):271–5.CrossRefPubMed
37.
Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2007;115(4):450–8.CrossRefPubMed
38.
Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. 2000;23(12):1835–9.CrossRefPubMed
39.
Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care. 2005;28(4):878–81.CrossRefPubMed
40.
Sarwar N, Sattar N. Triglycerides and coronary heart disease: have recent insights yielded conclusive answers? Curr Opin Lipidol. 2009;20(4):275–81.CrossRefPubMed
41.
42.
Wingard DL, Barrett-Connor E. Heart Disease and Diabetes. In: Diabetes in America. 2nd edn. Washington DC: US Government Printing Offices; 1995.
43.
Pearce N, Checkoway H, Kriebel D. Bias in occupational epidemiology studies. Occup Environ Med. 2007;64(8):562–8.CrossRefPubMed
44.
Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke. 1999;30(5):981–5.CrossRefPubMed
45.
Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, et al. Statin treatment and stroke outcome in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke. 2009;40(11):3526–31.CrossRefPubMed
46.
Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ (Clinical research ed). 1997;314(7090):1303–6.CrossRef
47.
Wong ND, Wilson PW, Kannel WB. Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study. Ann Intern Med. 1991;115(9):687–93.CrossRefPubMed
48.
Pietila KO, Harmoinen AP, Jokiniitty J, Pasternack AI. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J. 1996;17(9):1345–9.CrossRefPubMed
Metadata
Title
Multiple biomarker models for improved risk estimation of specific cardiovascular diseases related to metabolic syndrome: a cross-sectional study
Authors
Evan Coffman
Jennifer Richmond-Bryant
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Population Health Metrics / Issue 1/2015
Electronic ISSN: 1478-7954
DOI
https://doi.org/10.1186/s12963-015-0041-5

Other articles of this Issue 1/2015

Population Health Metrics 1/2015 Go to the issue

Research

Abdominal vs. overall obesity among women in a nutrition transition context: geographic and socio-economic patterns of abdominal-only obesity in Tunisia

Research

Ambient air pollution and adverse birth outcomes: a natural experiment study

Research

Estimating the current mean age of mothers at the birth of their first child from household surveys

Research

Improving the estimation of the burden of risk factors: an illustrative comparison of methods to measure smoking-attributable mortality

Research

Estimating distributions of health state severity for the global burden of disease study

Research

The longitudinal age and birth cohort trends of regular exercise among adults aged 16–63 years in Sweden: a 24-year follow-up study